{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:15:29Z","timestamp":1785158129425,"version":"3.55.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1002\/jcsm.12063","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T14:52:50Z","timestamp":1441205570000},"page":"275-277","source":"Crossref","is-referenced-by-count":34,"title":["Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin"],"prefix":"10.1002","volume":"6","author":[{"given":"Stefan D.","family":"Anker","sequence":"first","affiliation":[{"name":"Division of Innovative Clinical Trials, Department of Cardiology and Pneumology; University Medical Center G\u00f6ttingen (UMG); G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. S.","family":"Coats","sequence":"additional","affiliation":[{"name":"Monash University; Melbourne Australia"},{"name":"University of Warwick; Coventry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Morley","sequence":"additional","affiliation":[{"name":"Divisions of Geriatric Medicine and Endocrinology; Saint Louis University School of Medicine; St Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"10.1002\/jcsm.12063-BIB0001|jcsm12063-cit-0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jamda.2010.02.004","article-title":"Consensus on cachexia definitions","volume":"11","author":"Argiles","year":"2010","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0002|jcsm12063-cit-0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0003|jcsm12063-cit-0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13539-012-0099-x","article-title":"Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case-control study","volume":"4","author":"Omlin","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0004|jcsm12063-cit-0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drugs to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0005|jcsm12063-cit-0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jamda.2014.09.007","article-title":"Treatment of cachexia: an overview of recent developments","volume":"15","author":"Haehling","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0006|jcsm12063-cit-0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MCO.0b013e328359efd7","article-title":"Pathophysiology of the anorexia of aging","volume":"16","author":"Morley","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1002\/jcsm.12063-BIB0007|jcsm12063-cit-0007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomized controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1002\/jcsm.12063-BIB0008|jcsm12063-cit-0008","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab"},{"key":"10.1002\/jcsm.12063-BIB0009|jcsm12063-cit-0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nn1656","article-title":"Ghrelin controls hippocampal spine synapse density and memory performance","volume":"9","author":"Diano","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1002\/jcsm.12063-BIB0010|jcsm12063-cit-0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0196-9781(03)00160-8","article-title":"Grhelin-induced feeding is dependent on nitric oxide","volume":"24","author":"Gaskin","year":"2003","journal-title":"Peptides"},{"key":"10.1002\/jcsm.12063-BIB0011|jcsm12063-cit-0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomized, placebo-controlled, double-blind trials","volume":"16","author":"Garcia","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1002\/jcsm.12063-BIB0012|jcsm12063-cit-0012","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.fertnstert.2013.04.009","article-title":"Scientific overview of hormone treatment used for rejuvenation","volume":"99","author":"Morley","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1002\/jcsm.12063-BIB0013|jcsm12063-cit-0013","doi-asserted-by":"crossref","first-page":"852.e1","DOI":"10.1016\/j.jamda.2013.06.003","article-title":"Muscle quantity is not synonymous with muscle quality","volume":"14","author":"Barbat-Artigas","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0014|jcsm12063-cit-0014","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jamda.2014.04.021","article-title":"Validating the SARC-F: a suitable community screening tool for sarcopenia?","volume":"15","author":"Woo","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0015|jcsm12063-cit-0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/jcsm.12063-BIB0016|jcsm12063-cit-0016","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2013.06.026","article-title":"Body composition and survival in the early clinical trials setting","volume":"49","author":"Veasey Rodrigues","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1002\/jcsm.12063-BIB0017|jcsm12063-cit-0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","article-title":"Why cachexia kills: examining the causality of poor outcomes in wasting conditions","volume":"4","author":"Kalantar-Zadeh","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0018|jcsm12063-cit-0018","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase I trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1002\/jcsm.12063-BIB0019|jcsm12063-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-014-0135-0","article-title":"Muscle wasting disease: a proposal for a new disease classification","volume":"5","author":"Anker","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0020|jcsm12063-cit-0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","article-title":"Formoterol in the treatment of experimental cancer cachexia: effects on heart function","volume":"5","author":"Toledo","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0021|jcsm12063-cit-0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13539-014-0145-y","article-title":"Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?","volume":"5","author":"Fogelman","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0022|jcsm12063-cit-0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-014-0138-x","article-title":"An overview of amines as nutritional supplements to counteract cancer cachexia","volume":"5","author":"Campos-Ferraz","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0023|jcsm12063-cit-0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","article-title":"Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Rattanasompattikul","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0024|jcsm12063-cit-0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13539-014-0155-9","article-title":"Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone\/insulin-like growth factor-1 axis signaling in patients with advanced heart failure","volume":"5","author":"Khawaja","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0025|jcsm12063-cit-0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-013-0103-0","article-title":"Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS)","volume":"4","author":"Knops","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0026|jcsm12063-cit-0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13539-012-0097-z","article-title":"Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis","volume":"4","author":"Scott","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0027|jcsm12063-cit-0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12063-BIB0028|jcsm12063-cit-0028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-014-0132-3","article-title":"From sarcopenia to frailty: a road less traveled","volume":"5","author":"Morley","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcsm.12063","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcsm.12063\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:59:50Z","timestamp":1625313590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.12063"}},"subtitle":["Editorial"],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jcsm.12063","archive":["Portico"],"relation":{},"ISSN":["2190-5991"],"issn-type":[{"value":"2190-5991","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}